Fungarest

Fungarest may be available in the countries listed below.

Ingredient matches for Fungarest

Ketoconazole

Ketoconazole is reported as an ingredient of Fungarest in the following countries:

• Chile


• Spain

International Drug Name Search

Ropinirol Heumann

Ropinirol Heumann may be available in the countries listed below.

Ingredient matches for Ropinirol Heumann

Ropinirole

Ropinirole hydrochloride (a derivative of Ropinirole) is reported as an ingredient of Ropinirol Heumann in the following countries:

• Germany

International Drug Name Search

Zyclir

Zyclir may be available in the countries listed below.

Ingredient matches for Zyclir

Acyclovir

Aciclovir is reported as an ingredient of Zyclir in the following countries:

• Australia

International Drug Name Search

Nufadoxin Forte

Nufadoxin Forte may be available in the countries listed below.

Ingredient matches for Nufadoxin Forte

Isoniazid

Isoniazid is reported as an ingredient of Nufadoxin Forte in the following countries:

• Indonesia

Pyridoxine

Pyridoxine is reported as an ingredient of Nufadoxin Forte in the following countries:

• Indonesia

International Drug Name Search

Teoptic

Teoptic may be available in the countries listed below.

Ingredient matches for Teoptic

Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Teoptic in the following countries:

• Netherlands


• United Kingdom

International Drug Name Search

Betacorten

Betacorten may be available in the countries listed below.

Ingredient matches for Betacorten

Betamethasone

Betamethasone is reported as an ingredient of Betacorten in the following countries:

• Singapore

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Betacorten in the following countries:

• Israel

International Drug Name Search

Gadopentetic Acid

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V08CA01

CAS registry number (Chemical Abstracts Service)

0080529-93-7

Chemical Formula

C14-H20-Gd-N3-O10

Molecular Weight

547

Therapeutic Category

Contrast medium, NMR-tomography

Chemical Name

Gadolinate(2-), [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]-, dihydrogen

Foreign Names

• Acidum gadopenteticum (Latin)
• Gadopentetsäure (German)
• Acide gadopentétique (French)
• Acido gadopentetico (Spanish)

Generic Names

• Acide gadopentétique (OS: DCF)
• Gadopentetic Acid (OS: BAN)
• Gd-DTPA (IS: Schering)
• Gadopentetate Dimeglumine (OS: USAN)
• Meglumine Gadopentetate (OS: JAN, BANM)
• SHL 451 A (IS: Schering)
• Gadopentetate Dimeglumine (PH: USP 32)

Brand Names

• Gado-MRT-ratiopharm
  Ratiopharm, Germany



• Gadopentetate Insight
  Insight Agents, Luxembourg



• Magnegita
  Insight, Greece; Insight Agents, Austria; Insight Agents, Switzerland; Insight Agents, France; Insight Agents, Luxembourg



• Magnevist
  Bayer, Austria; Bayer, Belgium; Bayer, Canada; Bayer, Switzerland; Bayer, Germany; Bayer, Denmark; Bayer, Estonia; Bayer, Spain; Bayer, Croatia (Hrvatska); Bayer, Italy; Bayer, Lithuania; Bayer, Latvia; Bayer, New Zealand; Bayer, Peru; Bayer, Sweden; Bayer, Turkey; Bayer Animal Health, Luxembourg; Bayer Santé, France; Bayer Schering, Australia; Bayer Schering, Finland; Bayer Schering, Greece; Bayer Schering Pharma, Norway; Bayer Yakuhin, Japan; Berlex, United States; Schering, Argentina; Schering, Bosnia & Herzegowina; Schering, China; Schering, Colombia; Schering, Czech Republic; Schering, Algeria; Schering, Georgia; Schering, Hungary; Schering, Iceland; Schering, Oman; Schering, Poland; Schering, Romania; Schering, Serbia; Schering, Russian Federation; Schering, Slovenia; Schering, Tunisia



• Magnevistan
  Schering, Chile; Schering-Plough, Brazil



• Magnograf
  Bayer, Spain; Berlis, Switzerland



• MR-Lux
  Sanochemia, Switzerland; Sanochemia, Germany



• Viewgam
  Bacon, Argentina; Bacon, Peru

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

PerioChip

PerioChip is a brand name of chlorhexidine topical, approved by the FDA in the following formulation(s):

PERIOCHIP (chlorhexidine gluconate - tablet; dental)

• 
  Manufacturer: DEXCEL PHARMA
  
  Approval date: May 15, 1998
  
  Strength(s): 2.5MG ^[RLD]

Has a generic version of PerioChip been approved?

No. There is currently no therapeutically equivalent version of PerioChip available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of PerioChip. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with PerioChip.

See also...

• PerioChip Consumer Information (Cerner Multum)
• Chlorhexidine Liquid Consumer Information (Wolters Kluwer)
• Chlorhexidine Solution Consumer Information (Wolters Kluwer)
• Chlorhexidine gluconate oral rinse Consumer Information (Cerner Multum)
• Chlorhexidine topical Consumer Information (Cerner Multum)
• Biopatch w/Chlorhexidine Gluconate Advanced Consumer Information (Micromedex)
• Operand Chg Surgical Scrub Brush Advanced Consumer Information (Micromedex)
• Operand Chlorhexidine Gluconate Advanced Consumer Information (Micromedex)
• Operand Closed Loop Chg Scrub Advanced Consumer Information (Micromedex)
• Stanhexidine Solution Advanced Consumer Information (Micromedex)
• Stanley Chlorhexidine Tinted Advanced Consumer Information (Micromedex)
• Stanley Chlorhexidine Untinted Advanced Consumer Information (Micromedex)
• Chlorhexidine Advanced Consumer Information (Micromedex)
• Chlorhexidine Periodontal Advanced Consumer Information (Micromedex)
• Chlorhexidine Topical application Advanced Consumer Information (Micromedex)
• Chlorhexidine Gluconate eent AHFS DI Monographs (ASHP)
• Chlorhexidine Gluconate topical AHFS DI Monographs (ASHP)

Santocyn

Santocyn may be available in the countries listed below.

Ingredient matches for Santocyn

Oxytocin

Oxytocin is reported as an ingredient of Santocyn in the following countries:

• Indonesia

International Drug Name Search

Go-Gesic

Ingredient matches for Go-Gesic

Hydrocodone

Hydrocodone tartrate (a derivative of Hydrocodone) is reported as an ingredient of Go-Gesic in the following countries:

• United States

Paracetamol

Paracetamol is reported as an ingredient of Go-Gesic in the following countries:

• United States

International Drug Name Search

Aciclovir CristerS

Aciclovir CristerS may be available in the countries listed below.

Ingredient matches for Aciclovir CristerS

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir CristerS in the following countries:

• France

International Drug Name Search

Citarabina Martian

Citarabina Martian may be available in the countries listed below.

Ingredient matches for Citarabina Martian

Cytarabine

Cytarabine is reported as an ingredient of Citarabina Martian in the following countries:

• Argentina

International Drug Name Search

Emaberin

Emaberin may be available in the countries listed below.

Ingredient matches for Emaberin

Nifedipine

Nifedipine is reported as an ingredient of Emaberin in the following countries:

• Japan

International Drug Name Search

Mannitolo Eurospital

Mannitolo Eurospital may be available in the countries listed below.

Ingredient matches for Mannitolo Eurospital

Mannitol

Mannitol is reported as an ingredient of Mannitolo Eurospital in the following countries:

• Italy

International Drug Name Search

Phenolphtaleinum

Phenolphtaleinum may be available in the countries listed below.

Ingredient matches for Phenolphtaleinum

Phenolphthalein

Phenolphthalein is reported as an ingredient of Phenolphtaleinum in the following countries:

• Hungary

International Drug Name Search

Conexine

Conexine may be available in the countries listed below.

Ingredient matches for Conexine

Memantine

Memantine hydrochloride (a derivative of Memantine) is reported as an ingredient of Conexine in the following countries:

• Argentina

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Conexine in the following countries:

• Ecuador


• Venezuela

International Drug Name Search

Nerfin

Nerfin may be available in the countries listed below.

Ingredient matches for Nerfin

Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Nerfin in the following countries:

• Japan

International Drug Name Search

Domitor

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Domitor

Medetomidine

Medetomidine is reported as an ingredient of Domitor in the following countries:

• New Zealand


• United States

Medetomidine hydrochloride (a derivative of Medetomidine) is reported as an ingredient of Domitor in the following countries:

• Australia


• Austria


• Belgium


• Finland


• France


• Germany


• Ireland


• Italy


• Luxembourg


• Netherlands


• Norway


• Poland


• Portugal


• South Africa


• Sweden


• Switzerland


• United Kingdom

International Drug Name Search

Folrex

Folrex may be available in the countries listed below.

Ingredient matches for Folrex

Folic Acid

Folic Acid is reported as an ingredient of Folrex in the following countries:

• Venezuela

International Drug Name Search

Fivoflu

Fivoflu may be available in the countries listed below.

Ingredient matches for Fivoflu

Fluorouracil

Fluorouracil is reported as an ingredient of Fivoflu in the following countries:

• Philippines


• Sri Lanka

International Drug Name Search

Eugalac

Eugalac may be available in the countries listed below.

Ingredient matches for Eugalac

Lactulose

Lactulose is reported as an ingredient of Eugalac in the following countries:

• Germany

International Drug Name Search

Rispefar

Rispefar may be available in the countries listed below.

Ingredient matches for Rispefar

Risperidone

Risperidone is reported as an ingredient of Rispefar in the following countries:

• Poland

International Drug Name Search

Ventoplus

Ventoplus may be available in the countries listed below.

Ingredient matches for Ventoplus

Levosalbutamol

Levosalbutamol hydrochloride (a derivative of Levosalbutamol) is reported as an ingredient of Ventoplus in the following countries:

• Argentina

International Drug Name Search

Yatorip

Yatorip may be available in the countries listed below.

Ingredient matches for Yatorip

Icosapent

Icosapent ethyl ester (a derivative of Icosapent) is reported as an ingredient of Yatorip in the following countries:

• Japan

International Drug Name Search

Clarithromycine Abbott

Clarithromycine Abbott may be available in the countries listed below.

Ingredient matches for Clarithromycine Abbott

Clarithromycin

Clarithromycin is reported as an ingredient of Clarithromycine Abbott in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Normaln

Normaln may be available in the countries listed below.

Ingredient matches for Normaln

Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Normaln in the following countries:

• Japan

International Drug Name Search

Cefaklon

Cefaklon may be available in the countries listed below.

Ingredient matches for Cefaklon

Cefaclor

Cefaclor is reported as an ingredient of Cefaklon in the following countries:

• Argentina

International Drug Name Search

AK-Fluor

In the US, AK-Fluor (fluorescein systemic) is a member of the drug class ophthalmic diagnostic agents.

US matches:

• AK-FLUOR

Ingredient matches for AK-Fluor

Fluorescein

Fluorescein sodium (a derivative of Fluorescein) is reported as an ingredient of AK-Fluor in the following countries:

• Peru


• United States

International Drug Name Search

Izoneocol

Izoneocol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Izoneocol

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Izoneocol in the following countries:

• Italy

International Drug Name Search

Pirlimycin

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0079548-73-5

Chemical Formula

C17-H31-Cl-N2-O5-S

Molecular Weight

410

Therapeutic Category

Antibacterial: Lincomycin

Chemical Names

(2S-cis)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(4-ethyl-2-piperidinyl)carbonyl]-amino]-1-thio-L-threo-α-D-galacto-octopyranoside

Methyl 7-chlor-6,7,8-tridesoxy-6-(4α-ethyl-2α-piperidylcarboxamido)-1-thio-L-threo-α-D-galactooctopyranosid (IUPAC)

Methyl 7-chloro-6,7,8-trideoxy-6-(cis-4-ethyl-L-pipecolamido)-1-thio-L-threo-α-D-galactooctopyranoside (WHO)

Foreign Names

• Pirlimycinum (Latin)
• Pirlimycin (German)
• Pirlimycine (French)
• Pirlimicina (Spanish)

Generic Names

• U 57930E (IS: Upjohn)
• Pirlimycin Hydrochloride (OS: USAN)
• Pyrlimycin Hydrochloride Monohydrate (IS)
• U-57930 E (IS)

Brand Names

• Pirsue (veterinary use)
  Pfizer Limited, Austria; Pfizer Animal Health, Belgium; Pfizer Animal Health, Finland; Pfizer Animal Health, United Kingdom; Pfizer GmbH Tiergesundheit, Germany; Pfizer Santé Animale, France; Pharmacia & Upjohn vet, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Curatin

Curatin may be available in the countries listed below.

Ingredient matches for Curatin

Biotin

Biotin is reported as an ingredient of Curatin in the following countries:

• Austria

International Drug Name Search

Betavert

Betavert may be available in the countries listed below.

Ingredient matches for Betavert

Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Betavert in the following countries:

• Germany

Betahistine dimesilate (a derivative of Betahistine) is reported as an ingredient of Betavert in the following countries:

• Germany

International Drug Name Search

Fludarabine Actavis

Fludarabine Actavis may be available in the countries listed below.

Ingredient matches for Fludarabine Actavis

Fludarabine

Fludarabine phosphate (a derivative of Fludarabine) is reported as an ingredient of Fludarabine Actavis in the following countries:

• France

International Drug Name Search

Regoxal

Regoxal may be available in the countries listed below.

Ingredient matches for Regoxal

Bisoxatin

Bisoxatin diacetate (a derivative of Bisoxatin) is reported as an ingredient of Regoxal in the following countries:

• Venezuela

International Drug Name Search

Aciclovir-CT

Aciclovir-CT may be available in the countries listed below.

Ingredient matches for Aciclovir-CT

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir-CT in the following countries:

• Germany


• Luxembourg

International Drug Name Search

Folsyra Evolan

Folsyra Evolan may be available in the countries listed below.

Ingredient matches for Folsyra Evolan

Folic Acid

Folic Acid is reported as an ingredient of Folsyra Evolan in the following countries:

• Sweden

International Drug Name Search

Carteololo

Carteololo may be available in the countries listed below.

Ingredient matches for Carteololo

Carteolol

Carteololo (DCIT) is known as Carteolol in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Fuladic

Fuladic may be available in the countries listed below.

Ingredient matches for Fuladic

Fusidic Acid

Fusidic Acid is reported as an ingredient of Fuladic in the following countries:

• Indonesia

Fusidic Acid sodium (a derivative of Fusidic Acid) is reported as an ingredient of Fuladic in the following countries:

• Indonesia

International Drug Name Search

Steremal

Steremal may be available in the countries listed below.

Ingredient matches for Steremal

Prochlorperazine

Prochlorperazine maleate (a derivative of Prochlorperazine) is reported as an ingredient of Steremal in the following countries:

• Cyprus


• Kenya


• Malta


• Sudan


• Zimbabwe

International Drug Name Search

Indometacine PCH

Indometacine PCH may be available in the countries listed below.

Ingredient matches for Indometacine PCH

Indometacin

Indometacin is reported as an ingredient of Indometacine PCH in the following countries:

• Netherlands

International Drug Name Search

Sildenafil calox

Sildenafil calox may be available in the countries listed below.

Ingredient matches for Sildenafil calox

Sildenafil

Sildenafil is reported as an ingredient of Sildenafil calox in the following countries:

• Costa Rica


• Guatemala


• Honduras


• Nicaragua

International Drug Name Search

Locoid

In some countries, this medicine may only be approved for veterinary use.

In the US, Locoid (hydrocortisone topical) is a member of the drug class topical steroids and is used to treat Anal Itching, Aphthous Stomatitis - Recurrent, Atopic Dermatitis, Dermatitis, Eczema, Gingivitis, Proctitis, Pruritus, Psoriasis, Seborrheic Dermatitis, Skin Rash and Ulcerative Colitis - Active.

US matches:

• Locoid Cream


• Locoid Solution


• Locoid


• Locoid Lipocream


• Locoid Lotion


• Locoid Lipocream Topical application


• Locoid Topical application


• Locoid Ointment

UK matches:

• Locoid Cream (SPC)
• Locoid Crelo (SPC)
• Locoid Lipocream (SPC)
• Locoid Ointment (SPC)
• Locoid Scalp Lotion (SPC)

Ingredient matches for Locoid

Hydrocortisone

Hydrocortisone is reported as an ingredient of Locoid in the following countries:

• Japan

Hydrocortisone 17α-butyrate (a derivative of Hydrocortisone) is reported as an ingredient of Locoid in the following countries:

• Argentina


• Belgium


• Brazil


• Czech Republic


• Denmark


• Estonia


• Finland


• Hungary


• Iceland


• Ireland


• Latvia


• Luxembourg


• Malta


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Poland


• Portugal


• Romania


• Russian Federation


• South Africa


• Sweden


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ivostin

Ivostin may be available in the countries listed below.

Ingredient matches for Ivostin

Levocabastine

Levocabastine hydrochloride (a derivative of Levocabastine) is reported as an ingredient of Ivostin in the following countries:

• Israel

International Drug Name Search

Adco-Metronidazole

Adco-Metronidazole may be available in the countries listed below.

Ingredient matches for Adco-Metronidazole

Metronidazole

Metronidazole is reported as an ingredient of Adco-Metronidazole in the following countries:

• South Africa

International Drug Name Search

Nifedipin Verla

Nifedipin Verla may be available in the countries listed below.

Ingredient matches for Nifedipin Verla

Nifedipine

Nifedipine is reported as an ingredient of Nifedipin Verla in the following countries:

• Germany

International Drug Name Search

Vermineo

Vermineo may be available in the countries listed below.

Ingredient matches for Vermineo

Piperazine

Piperazine is reported as an ingredient of Vermineo in the following countries:

• Colombia

International Drug Name Search

Fraxodi

Fraxodi may be available in the countries listed below.

Ingredient matches for Fraxodi

Nadroparin Calcium

Nadroparin Calcium is reported as an ingredient of Fraxodi in the following countries:

• Belgium


• France


• Germany


• Hungary


• Italy


• Luxembourg


• Netherlands


• Oman


• Poland


• Portugal


• Tunisia


• Turkey

International Drug Name Search

Acimed

Acimed may be available in the countries listed below.

Ingredient matches for Acimed

Omeprazole

Omeprazole is reported as an ingredient of Acimed in the following countries:

• Argentina

International Drug Name Search

Viru-Pos

Viru-Pos may be available in the countries listed below.

Ingredient matches for Viru-Pos

Acyclovir

Aciclovir is reported as an ingredient of Viru-Pos in the following countries:

• Poland

International Drug Name Search

Sorine Pediàtrico

Sorine Pediàtrico may be available in the countries listed below.

Ingredient matches for Sorine Pediàtrico

Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Sorine Pediàtrico in the following countries:

• Brazil

International Drug Name Search

Delagil

Delagil may be available in the countries listed below.

Ingredient matches for Delagil

Chloroquine

Chloroquine is reported as an ingredient of Delagil in the following countries:

• Russian Federation

Chloroquine phosphate (a derivative of Chloroquine) is reported as an ingredient of Delagil in the following countries:

• Czech Republic


• Ethiopia


• Georgia


• Hungary


• Slovakia

International Drug Name Search

Skinocyclin

Skinocyclin may be available in the countries listed below.

Ingredient matches for Skinocyclin

Minocycline

Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Skinocyclin in the following countries:

• Germany

International Drug Name Search

Fluditec toux sèche

Fluditec toux sèche may be available in the countries listed below.

Ingredient matches for Fluditec toux sèche

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Fluditec toux sèche in the following countries:

• France

International Drug Name Search

Pro Ulco

Pro Ulco may be available in the countries listed below.

Ingredient matches for Pro Ulco

Lansoprazole

Lansoprazole is reported as an ingredient of Pro Ulco in the following countries:

• Spain

International Drug Name Search

Fusix

Fusix may be available in the countries listed below.

Ingredient matches for Fusix

Furosemide

Furosemide is reported as an ingredient of Fusix in the following countries:

• Bahrain


• Ethiopia


• Oman

International Drug Name Search

Zolpidem Genfar

Zolpidem Genfar may be available in the countries listed below.

Ingredient matches for Zolpidem Genfar

Zolpidem

Zolpidem is reported as an ingredient of Zolpidem Genfar in the following countries:

• Colombia

International Drug Name Search

Diabetase

Diabetase may be available in the countries listed below.

Ingredient matches for Diabetase

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Diabetase in the following countries:

• Germany

International Drug Name Search

Duradrin

Generic Name: acetaminophen, dichloralphenazone, and isometheptene (a SEET a MIN oh fen, dye KLOR al FEN a zone, EYE soe me THEP teen)

Brand Names: Epidrin, Midrin, Migquin, Migragesic IDA

What is Duradrin (acetaminophen, dichloralphenazone, and isometheptene)?

Acetaminophen is a pain reliever and a fever reducer.

Dichloralphenazone is a sedative that slows the central nervous system.

Isometheptene causes narrowing of blood vessels (vasoconstriction).

The combination of acetaminophen, dichloralphenazone, and isometheptene is used to treat migraine headaches or severe tension headaches.

Acetaminophen, dichloralphenazone, and isometheptene may also be used for purposes not listed in this medication guide.

What is the most important information I should know about Duradrin (acetaminophen, dichloralphenazone, and isometheptene)?

Do not take more of this medication than is recommended. An overdose of acetaminophen can damage your liver or cause death. Tell your doctor if you have ever had alcoholic liver disease (cirrhosis) or if you drink more than 3 alcoholic beverages per day. You may not be able to take medicine that contains acetaminophen. Avoid drinking alcohol. It may increase your risk of liver damage while taking acetaminophen. You should not take acetaminophen, dichloralphenazone, and isometheptene if you are allergic to acetaminophen (Tylenol), dichloralphenazone, isometheptene, or chloral hydrate (Somnote), or if you have glaucoma or if you are also taking sodium oxybate (Xyrem). Do not take more than 5 capsules in 12 hours to treat a migraine, or 8 capsules in 24 hours to treat a tension headache. Ask a doctor or pharmacist before using any other pain, cold, allergy, or sleep medication. Acetaminophen (sometimes abbreviated as APAP) is contained in many combination medicines. Taking certain products together can cause you to get too much acetaminophen which can lead to a fatal overdose. Check the label to see if a medicine contains acetaminophen or APAP. Do not use acetaminophen, dichloralphenazone, and isometheptene if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

What should I discuss with my healthcare provider before taking Duradrin (acetaminophen, dichloralphenazone, and isometheptene)?

Do not take this medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. Tell your doctor if you have ever had alcoholic liver disease (cirrhosis) or if you drink more than 3 alcoholic beverages per day. You may not be able to take medicine that contains acetaminophen. You should not take this medication if you are allergic to acetaminophen (Tylenol), dichloralphenazone, isometheptene, or chloral hydrate (Somnote), or if you have:

• 
  

  glaucoma; or

  
  


• 
  

  if you are also taking sodium oxybate (Xyrem).

  
  

To make sure you can safely take acetaminophen, dichloralphenazone, and isometheptene, tell your doctor if you have any of these other conditions:

• liver disease or cirrhosis;


• kidney disease;


• 
  

  coronary artery disease, circulation problems;

  
  


• 
  

  high blood pressure;

  
  


• 
  

  stomach ulcer or problems with your esophagus;

  
  


• 
  

  depression;

  
  


• 
  

  a history of drug or alcohol addiction; or

  
  


• 
  

  if you have recently had a stroke or heart attack.

  
  

FDA pregnancy category C. It is not known whether acetaminophen, dichloralphenazone, and isometheptene will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. This medication can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Duradrin (acetaminophen, dichloralphenazone, and isometheptene)?

Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Do not take more of this medication than is recommended. An overdose of acetaminophen can damage your liver or cause death.

You may take this medication with or without food.

Take the medicine with a full glass of water.

To treat migraine headache pain:

• 
  

  Take the first dose of this medication as soon as you notice headache symptoms, or after an attack has already begun.

  
  


• 
  

  If your headache does not completely go away, take 1 capsule every hour until you feel relief.

  
  


• 
  

  Do not take more than a total of 5 capsules in any 12-hour period to treat a migraine.

  
  


• 
  

  If you still have migraine symptoms after taking a total of 5 capsules, call your doctor.

  
  

To treat tension headache pain:

• 
  

  Take the first dose of this medication as soon as you notice tension headache symptoms.

  
  


• 
  

  If your headache does not completely go away, take 1 capsule every 4 hours until you feel relief.

  
  


• 
  

  Do not take more than a total of 8 capsules in any 24-hour period to treat a tension headache.

  
  


• 
  

  If you still have tension headache pain after taking a total of 8 capsules, call your doctor.

  
  

Call your doctor if this medication seems to stop working as well in relieving your pain. Also call your doctor if your headaches get worse or you have more than 2 headaches per week.

Do not stop using this medicine suddenly if you have been using it for longer than 2 weeks in a row, or you could have unpleasant withdrawal symptoms. Talk to your doctor about how to avoid withdrawal symptoms when you stop using acetaminophen, dichloralphenazone, and isometheptene. If you need surgery, tell the surgeon ahead of time that you are using this medication.

This medication can cause unusual results with certain lab tests for glucose (sugar) in the urine. Tell any doctor who treats you that you are using acetaminophen, dichloralphenazone, and isometheptene.

Store at room temperature away from moisture, heat, and light.

What happens if I miss a dose?

Since this medicine is used as needed, it does not have a daily dosing schedule. Call your doctor promptly if your symptoms do not improve after using acetaminophen, dichloralphenazone, and isometheptene.

Do not take more than 5 capsules in 12 hours to treat a migraine, or 8 capsules in 24 hours to treat a tension headache.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of acetaminophen can damage your liver or cause death.

The first signs of an acetaminophen overdose include loss of appetite, nausea, vomiting, stomach pain, sweating, and confusion or weakness. Later symptoms may include pain in your upper stomach, dark urine, and yellowing of your skin or the whites of your eyes.

Other overdose symptoms may include severe dizziness or drowsiness, feeling restless or cold, changes in your breathing or heart rate, and fainting.

What should I avoid while taking Duradrin (acetaminophen, dichloralphenazone, and isometheptene)?

This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Avoid drinking alcohol. It may increase your risk of liver damage while taking acetaminophen. Ask a doctor or pharmacist before using any other pain, cold, allergy, or sleep medication. Acetaminophen (sometimes abbreviated as APAP) is contained in many combination medicines. Taking certain products together can cause you to get too much acetaminophen which can lead to a fatal overdose. Check the label to see if a medicine contains acetaminophen or APAP.

Duradrin (acetaminophen, dichloralphenazone, and isometheptene) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using the medicine and call your doctor at once if you have a serious side effect such as:

• 
  

  low fever with nausea, stomach pain, and loss of appetite;

  
  


• 
  

  dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);

  
  


• 
  

  fast or uneven heart rate;

  
  


• 
  

  easy bruising or bleeding, unusual weakness; or

  
  


• 
  

  fever, chills, sore throat, body aches, flu symptoms.

  
  

Less serious side effects may include:

• 
  

  dizziness, drowsiness;

  
  


• 
  

  mild nausea; or

  
  


• 
  

  mood changes.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Duradrin (acetaminophen, dichloralphenazone, and isometheptene)?

Before using this medication, tell your doctor if you regularly use other medicines that make you sleepy (such as cold or allergy medicine, sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by acetaminophen, dichloralphenazone, and isometheptene.

Tell your doctor about all other medications you use, especially:

• 
  

  a blood thinner such as warfarin (Coumadin, Jantoven);

  
  


• 
  

  isoniazid (for treating tuberculosis); or

  
  


• 
  

  an antidepressant such as amitriptyline (Elavil, Limbitrol, Vanatrip), doxepin (Sinequan), desipramine (Norpramin), imipramine (Janimine, Tofranil), nortriptyline (Pamelor), and others.

  
  

This list is not complete and other drugs may interact with acetaminophen, dichloralphenazone, and isometheptene. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More Duradrin resources

• Duradrin Side Effects (in more detail)
• Duradrin Use in Pregnancy & Breastfeeding
• Drug Images
• Duradrin Drug Interactions
• Duradrin Support Group
• 1 Review for Duradrin - Add your own review/rating

• Duradrin Advanced Consumer (Micromedex) - Includes Dosage Information


• Duradrin MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Duradrin with other medications

• Headache

Where can I get more information?

• Your pharmacist can provide more information about acetaminophen, dichloralphenazone, and isometheptene.

See also: Duradrin side effects (in more detail)

Ranitol

Ranitol may be available in the countries listed below.

Ingredient matches for Ranitol

Ranitidine

Ranitidine is reported as an ingredient of Ranitol in the following countries:

• Ethiopia

International Drug Name Search

benazepril

ben-AZ-e-pril

Oral route(Tablet)

ACE inhibitors can cause injury or death to the developing fetus when used during the second and third trimesters. Stop therapy as soon as possible when pregnancy is detected .

Commonly used brand name(s)

In the U.S.

• Lotensin

Available Dosage Forms:

• Tablet

Therapeutic Class: Antihypertensive

Pharmacologic Class: ACE Inhibitor

Uses For benazepril

Benazepril is used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the work load of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Hypertension may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled .

Benazepril works by blocking an enzyme in the body that is necessary to produce a substance that causes blood vessels to tighten. As a result, the blood vessels relax. This lowers blood pressure and increases the supply of blood and oxygen to the heart .

benazepril is available only with your doctor's prescription .

Before Using benazepril

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For benazepril, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to benazepril or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatrics-specific problems that would limit the usefulness of benazepril in children with hypertension who are 6 to 16 years of age. Safety and efficacy have not been established in children who are 5 years old and younger .

Geriatric

Appropriate studies performed to date have not demonstrated geriatrics-specific problems that would limit the usefulness of benazepril in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require an adjustment of dose in patients receiving benazepril .

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	D	Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking benazepril, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using benazepril with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Alteplase, Recombinant


• Amiloride


• Azathioprine


• Azilsartan Medoxomil


• Candesartan Cilexetil


• Canrenoate


• Eplerenone


• Eprosartan


• Losartan


• Olmesartan Medoxomil


• Potassium


• Spironolactone


• Telmisartan


• Triamterene


• Valsartan

Using benazepril with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Aceclofenac


• Acemetacin


• Alclofenac


• Aliskiren


• Apazone


• Azosemide


• Bemetizide


• Bendroflumethiazide


• Benoxaprofen


• Benzthiazide


• Bromfenac


• Bufexamac


• Bumetanide


• Bupivacaine


• Buthiazide


• Capsaicin


• Carprofen


• Chlorothiazide


• Chlorthalidone


• Clometacin


• Clonixin


• Clopamide


• Cyclopenthiazide


• Cyclothiazide


• Dexketoprofen


• Diclofenac


• Diflunisal


• Dipyrone


• Droxicam


• Ethacrynic Acid


• Etodolac


• Etofenamate


• Felbinac


• Fenbufen


• Fenoprofen


• Fentiazac


• Floctafenine


• Flufenamic Acid


• Flurbiprofen


• Furosemide


• Gold Sodium Thiomalate


• Hydrochlorothiazide


• Hydroflumethiazide


• Ibuprofen


• Indapamide


• Indomethacin


• Indoprofen


• Isoxicam


• Ketoprofen


• Ketorolac


• Lithium


• Lornoxicam


• Meclofenamate


• Mefenamic Acid


• Meloxicam


• Methyclothiazide


• Metolazone


• Nabumetone


• Naproxen


• Nesiritide


• Niflumic Acid


• Nimesulide


• Oxaprozin


• Oxyphenbutazone


• Phenylbutazone


• Pirazolac


• Piretanide


• Piroxicam


• Pirprofen


• Polythiazide


• Propyphenazone


• Proquazone


• Quinethazone


• Sulindac


• Suprofen


• Tenidap


• Tenoxicam


• Tiaprofenic Acid


• Tolmetin


• Torsemide


• Trichlormethiazide


• Xipamide


• Zomepirac

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of benazepril. Make sure you tell your doctor if you have any other medical problems, especially:

• Angioedema, history of—Benazepril may increase the risk of this condition occurring again .

• Dehydration or


• Diarrhea or


• Heart failure or


• Hyponatremia (low sodium in the blood) or


• Kidney disease—These conditions may cause the blood pressure to fall too low with benazepril .

Proper Use of benazepril

In addition to the use of benazepril, treatment for your high blood pressure may include weight control and changes in the types of foods you eat, especially foods high in sodium. Your doctor will tell you which of these are most important for you. You should check with your doctor before changing your diet.

Many patients who have high blood pressure will not notice any signs of the problem. In fact, many may feel normal. It is very important that you take your medicine exactly as directed and that you keep your appointments with your doctor even if you feel well.

Remember that benazepril will not cure your high blood pressure but it does help control it. Therefore, you must continue to take it as directed if you expect to lower your blood pressure and keep it down. You may have to take high blood pressure medicine for the rest of your life. If high blood pressure is not treated, it can cause serious problems such as heart failure, blood vessel disease, stroke, or kidney disease.

Dosing

The dose of benazepril will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of benazepril. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage form (tablets):
  
  • For high blood pressure:
    
    • Adults—At first, 10 milligrams (mg) once a day. Then, your doctor may increase your dose to 20 to 40 mg per day taken as a single dose or divided into two doses.
    
    
    • Children 6 years of age and older—The dose is based on body weight and must be determined by your doctor.
    
    
    • Children under 6 years of age—Use and dose must be determined by your doctor .
    
    
  
  

Missed Dose

If you miss a dose of benazepril, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using benazepril

It is very important that your doctor check your progress at regular visits to make sure benazepril is working properly and to check for unwanted effects .

Using benazepril while you are pregnant can harm your unborn baby. If you think you have become pregnant while using benazepril, tell your doctor right away .

Stop using benazepril and call your doctor right away if you have swelling of the face, arms, legs, eyes, lips, or tongue, or problems with swallowing or breathing. These are symptoms of a condition called angioedema .

Stop using benazepril and call your doctor right away if you have severe stomach pain. This could be a symptom of a condition called intestinal angioedema .

You may experience lightheadedness during the first few days with benazepril. If this becomes severe and you faint, stop using benazepril and talk to your doctor right away .

Tell your doctor immediately if you have any signs of infection such as chills, sore throat, or fever. These may be symptoms of an immune system condition called neutropenia .

If your symptoms do not improve within a few days or if they become worse, check with your doctor .

benazepril may increase the amount of potassium in your blood. Do not use salt substitutes containing potassium without first checking with your doctor .

Check with your doctor right away if you have symptoms of jaundice (yellow skin or eyes) because these may be signs of a serious liver condition .

Make sure any doctor or dentist who treats you knows that you are using benazepril. You may need to stop using benazepril several days before having surgery or medical tests .

benazepril Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Less common

• Chills


• cold sweats


• confusion


• dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Headache

Less common

• Cough


• nausea


• sleepiness or unusual drowsiness


• unusual tiredness or weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: benazepril side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More benazepril resources

• Benazepril Side Effects (in more detail)
• Benazepril Dosage
• Benazepril Use in Pregnancy & Breastfeeding
• Drug Images
• Benazepril Drug Interactions
• Benazepril Support Group
• 5 Reviews for Benazepril - Add your own review/rating

• Benazepril MedFacts Consumer Leaflet (Wolters Kluwer)


• Benazepril Prescribing Information (FDA)


• Benazepril Hydrochloride Monograph (AHFS DI)


• Lotensin Prescribing Information (FDA)


• Lotensin Consumer Overview

Compare benazepril with other medications

• Diabetic Kidney Disease
• Heart Failure
• High Blood Pressure
• Left Ventricular Dysfunction

Dextromethorfan Samenwerkende Apothekers

Dextromethorfan Samenwerkende Apothekers may be available in the countries listed below.

Ingredient matches for Dextromethorfan Samenwerkende Apothekers

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Dextromethorfan Samenwerkende Apothekers in the following countries:

• Netherlands

International Drug Name Search

Diclofenac Sandoz

Diclofenac Sandoz may be available in the countries listed below.

Ingredient matches for Diclofenac Sandoz

Diclofenac

Diclofenac is reported as an ingredient of Diclofenac Sandoz in the following countries:

• Luxembourg

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Sandoz in the following countries:

• Austria


• Belgium


• Germany


• Italy


• Netherlands


• Portugal


• Switzerland

International Drug Name Search

Furosemide Katwijk

Furosemide Katwijk may be available in the countries listed below.

Ingredient matches for Furosemide Katwijk

Furosemide

Furosemide is reported as an ingredient of Furosemide Katwijk in the following countries:

• Netherlands

International Drug Name Search

Ceftriaxone ABC

Ceftriaxone ABC may be available in the countries listed below.

Ingredient matches for Ceftriaxone ABC

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ceftriaxone ABC in the following countries:

• Italy

International Drug Name Search

Fentatienil

Fentatienil may be available in the countries listed below.

Ingredient matches for Fentatienil

Sufentanil

Sufentanil citrate (a derivative of Sufentanil) is reported as an ingredient of Fentatienil in the following countries:

• Italy

International Drug Name Search

Elcodrint

Elcodrint may be available in the countries listed below.

Ingredient matches for Elcodrint

Mometasone

Mometasone is reported as an ingredient of Elcodrint in the following countries:

• Peru

International Drug Name Search

Symax

Ingredient matches for Symax

Hyoscyamine

Hyoscyamine sulfate (a derivative of Hyoscyamine) is reported as an ingredient of Symax in the following countries:

• United States

International Drug Name Search

Cetrimide

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D08AJ04,D11AC01

CAS registry number (Chemical Abstracts Service)

0008044-71-1

Therapeutic Categories

Antiseptic

Disinfectant

Chemical Name

Mixture of chiefly tetradecyltrimethylammonium bromide with smaller amounts of dodecyltrimethylammonium bromide and hexadecyltrimethylammonium bromide

Foreign Names

• Cetrimidum (Latin)
• Cetrimid (German)
• Cétrimide (French)
• Cetrimida (Spanish)

Generic Names

• Cetrimide (OS: JAN, BAN)
• Cétrimide (OS: DCF)
• Zetrimid (IS)
• Cetrimid (PH: Ph. Eur. 6)
• Cetrimide (PH: BP 2010, Ph. Int. 4, USP 30, Ph. Eur. 6)
• Cétrimide (PH: Ph. Eur. 6)
• Cetrimidum (PH: Ph. Int. 4, Ph. Eur. 6)
• Strong Cetrimide Solution (PH: BP 2010)

Brand Names

• Acnederm Foam Wash (Cetrimide and Chlorhexindine)
  Ego, New Zealand



• Antiseptic Udder Cream (Cetrimide and Chlorhexidine (veterinary use))
  DeLaval, Australia



• Aseptol (Cetrimide and Chlorhexidine (veterinary use))
  Apex Laboratories, Australia



• Baxidin (Cetrimide and Chlorhexidine)
  Sanitas, Italy



• Benzomid (Cetrimide and Benzocaine)
  Surya Dermato Medica, Indonesia



• Biodicaine (Cetrimide and Lidocaine)
  Biodica, France



• Boucren
  Bouzen, Argentina



• Burnol
  Boots, Singapore



• Cet A Creme (veterinary use)
  AgVantage Animal Health Products, Australia



• Cetavlex
  AstraZeneca, United Arab Emirates; AstraZeneca, Bahrain; AstraZeneca, Egypt; AstraZeneca, Iraq; AstraZeneca, Jordan; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Libya; AstraZeneca, Qatar; AstraZeneca, Saudi Arabia; AstraZeneca, Syria; AstraZeneca, Yemen; Bioglan, Iceland; Centrapharm, United Kingdom; CS, Portugal; Tramedico, Luxembourg



• Cetavlon
  Cana, Greece; Pierre Fabre, Burkina Faso; Pierre Fabre, Benin; Pierre Fabre, Central African Republic; Pierre Fabre, Congo; Pierre Fabre, Cote D'ivoire; Pierre Fabre, Cameroon; Pierre Fabre, Gabon; Pierre Fabre, Guinea; Pierre Fabre, Madagascar; Pierre Fabre, Mali; Pierre Fabre, Mauritania; Pierre Fabre, Niger; Pierre Fabre, Senegal; Pierre Fabre, Chad; Pierre Fabre, Togo; Pierre Fabre, Vietnam; Pierre Fabre, Zaire; Pierre Fabre Médicament, France



• Cetream (veterinary use)
  Pettifer, United Kingdom



• Cetrexidin (Cetrimide and Chlorhexidine)
  Gaba Vebas, Italy



• Cetriad (veterinary use)
  Fort Dodge, United Kingdom



• Cetridine (Cetrimide and Chlorhexidine (veterinary use))
  Mavlab, Australia



• Cetrifarm (Cetrimide and Chlorhexidine)
  Nuova Farmec, Italy



• Cetrimide Shampoo
  Orion, New Zealand



• Cetrimide
  Orion, New Zealand; Pharco, Bahrain; PSM, New Zealand; Vitamed, Israel



• Cevlodil
  Saidal, Algeria



• Chemilon Antiseptic Solution (Cetrimide and Chlorhexidine)
  Multichem, New Zealand



• Chlorhexidine & Cetrimide Irrigation (Cetrimide and Chlorhexidine)
  Baxter, New Zealand; Pfizer, New Zealand



• Corneregel (Cetrimide and Dexpanthenol)
  Riel, Austria



• Dicagel (Cetrimide and Lidocaine)
  Biodica, France



• Drapolene (Cetrimide and Benzalkonium chloride)
  Chefaro, United Kingdom



• Eczema (Cetrimide andAminobenzoic Acid (veterinary use))
  Bomac, New Zealand



• Equis Fre Itch (veterinary use)
  Mavlab, Australia



• Farvicett (Cetrimide and Chlorhexidine)
  Nuova Farmec, Italy



• Fido's Mycodex (veterinary use)
  Mavlab, Australia



• Foot Rot Aerosol (veterinary use)
  Battle, United Kingdom



• Hibicet (Cetrimide and Chlorhexidine)
  Cana, Greece; Regent Medical, Netherlands



• Karicare Barrier Cream (Cetrimide and Dimeticone)
  Nutricia, New Zealand



• Lanacane C (Cetrimide and Benzocaie)
  Wilson, New Zealand



• Lidocaina Ogna (Cetrimide and Lidocaine)
  Ogna, Italy



• Lignosol (Cetrimide and Lidocaine)
  Arab Center, Oman; Arab Centre, Bahrain



• Lysocalmspray (Cetrimide and Lidocaine)
  Pierre Fabre Médicament, France



• Morhonine For Dental Use (Cetrimide and Edetic Acid)
  Showa Yakuhin Kako, Japan



• Neo Resiguard (Cetrimide and Chlorhexidine)
  Nicholas, Indonesia



• Savlon (Cetrimide and Chlorhexidine)
  AstraZeneca, Oman; Reckitt Benckiser, New Zealand



• Siopel (Cetrimide and Dimeticone)
  Centrapharm, United Kingdom



• SOOV Bite (Cetrimide and Lidocaine)
  Ego, New Zealand



• Sorbicet
  Bouzen, Argentina



• Stérilène
  Gifrer Barbezat, France



• Tecsep (Cetrimide and Chlorhexidine (veterinary use))
  Virbac, New Zealand



• Tisept (Cetrimide and Chlorhexidine)
  Mölnlycke, United Kingdom



• Travasept (Cetrimide and Chlorhexidine)
  Baxter, United Kingdom



• Trochain (Cetrimide and Benzocaine)
  Adcock Ingram Pharmaceuticals, South Africa



• Vanodine Udder Salve (veterinary use)
  Evans Vanodine, United Kingdom



• Vesagex
  Rybar, Ireland



• Veterinary Wound Powder (veterinary use)
  Battle, United Kingdom



• Vetzyme Veterinary Skin Cream (veterinary use)
  Seven Seas, United Kingdom



• Vidisic
  Angelini, Portugal; Mann, Ireland; Riel, Austria



• Woundcare Powder (veterinary use)
  Animalcare, United Kingdom



• Xylonor (Cetrimide and Lidocaine)
  Septodont, Austria; Wild, Switzerland; Prats, Spain; Sanolabor, Slovenia

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Berbesolone F

Berbesolone F may be available in the countries listed below.

Ingredient matches for Berbesolone F

Betamethasone

Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Berbesolone F in the following countries:

• Japan

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Berbesolone F in the following countries:

• Japan

International Drug Name Search

Fortonol

Fortonol may be available in the countries listed below.

Ingredient matches for Fortonol

Acenocoumarol

Acenocoumarol is reported as an ingredient of Fortonol in the following countries:

• Argentina

International Drug Name Search

Totalon

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Totalon

Levamisole

Levamisole is reported as an ingredient of Totalon in the following countries:

• United States

International Drug Name Search

Acido Ascorbico

Acido Ascorbico may be available in the countries listed below.

Ingredient matches for Acido Ascorbico

Ascorbic Acid

Acido Ascorbico (DCIT) is known as Ascorbic Acid in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

DextroStat

In the US, DextroStat (dextroamphetamine systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Hypersomnia, Narcolepsy and Sexual Dysfunction - SSRI Induced.

US matches:

• Dextrostat

Ingredient matches for DextroStat

Dexamfetamine

Dexamfetamine is reported as an ingredient of DextroStat in the following countries:

• United States

Dexamfetamine sulfate (a derivative of Dexamfetamine) is reported as an ingredient of DextroStat in the following countries:

• United States

International Drug Name Search

Tafil

Tafil may be available in the countries listed below.

Ingredient matches for Tafil

Alprazolam

Alprazolam is reported as an ingredient of Tafil in the following countries:

• Costa Rica


• Denmark


• El Salvador


• Germany


• Guatemala


• Honduras


• Iceland


• Mexico


• Nicaragua


• Panama


• Venezuela

International Drug Name Search

Respa-AR Sustained-Release Tablets

Pronunciation: bell-a-DON-a AL-ka-loids/klor-fen-EER-a-meen/sue-do-eh-FED-rin
Generic Name: Belladonna Alkaloids/Chlorpheniramine/Pseudoephedrine
Brand Name: Examples include Respa-AR and Ru-Tuss

Respa-AR Sustained-Release Tablets are used for:

Relieving congestion, sneezing, runny nose, and itchy, watery eyes due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Respa-AR Sustained-Release Tablets are an antihistamine, decongestant, and anticholinergic combination. It works by blocking histamine, a substance in the body that causes sneezing, runny nose, and watery eyes. It also relieves nasal congestion by shrinking the nasal mucous membranes, which promotes nasal drainage, and dries the chest by decreasing lung secretions.

Do NOT use Respa-AR Sustained-Release Tablets if:

• you are allergic to any ingredient in Respa-AR Sustained-Release Tablets


• you are pregnant or breast-feeding


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days


• you have severe heart blood vessel disease, severe high blood pressure, narrow-angle glaucoma, severe bleeding, severe irritation of the esophagus or other serious problems with the esophagus (eg, esophageal achalasia), peptic ulcer, a blockage of your stomach or bowel, bowel motility problems, severe bowel inflammation (eg, ulcerative colitis), certain muscle problems (eg, myasthenia gravis), or uncontrolled bleeding


• you are unable to urinate or are having an asthma attack

Contact your doctor or health care provider right away if any of these apply to you.

Before using Respa-AR Sustained-Release Tablets:

Some medical conditions may interact with Respa-AR Sustained-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are planning to become pregnant


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of diabetes, an enlarged prostate, bladder or kidney problems, high blood pressure, diarrhea, asthma, nerve problems, heart problems, blood clots, a hiatal hernia, an adrenal gland tumor, glaucoma, breathing problems during sleep, seizures, myasthenia gravis (muscle weakness), or an overactive thyroid

Some MEDICINES MAY INTERACT with Respa-AR Sustained-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Alpha-blockers (eg, prazosin, guanethidine, methyldopa), beta-blockers (eg, atenolol), diuretics (eg, furosemide, hydrochlorothiazide), furazolidone, MAO inhibitors (eg, phenelzine), or tricyclic antidepressants (eg, amitriptyline)


• Alkalizers (eg, calcium or magnesium antacids), anticholinergics (eg, atropine, benztropine, dicyclomine), carbonic anhydrase inhibitors (eg, acetazolamide), ergotamine, or sodium bicarbonate because the side effects of Respa-AR Sustained-Release Tablets may be increased


• Bromocriptine, catechol-O-methyltransferase (COMT) inhibitors (eg, entacapone), certain stimulants (eg, doxapram, pseudoephedrine), cocaine, digoxin, droxidopa, potassium chloride, or sodium oxybate (GHB) because side effects may be increased by Respa-AR Sustained-Release Tablets


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because effectiveness may be decreased by Respa-AR Sustained-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Respa-AR Sustained-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Respa-AR Sustained-Release Tablets:

Use Respa-AR Sustained-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Respa-AR Sustained-Release Tablets may be taken with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Do not take Respa-AR Sustained-Release Tablets at the same time as an antacid, certain medicines for diarrhea (eg, kaolin, pectin, attapulgite, bismuth), or ketoconazole. Take these medicines 2 or 3 hours before or after taking Respa-AR Sustained-Release Tablets.


• Swallow whole. Do not crush or chew before swallowing. Some brands of Respa-AR Sustained-Release Tablets may be broken in half before they are taken. If you have difficulty swallowing the whole tablet, ask your pharmacist if your brand may be broken in half.


• If you miss a dose of Respa-AR Sustained-Release Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Respa-AR Sustained-Release Tablets.

Important safety information:

• Respa-AR Sustained-Release Tablets may cause drowsiness, dizziness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Respa-AR Sustained-Release Tablets. Using Respa-AR Sustained-Release Tablets alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• If your symptoms do not improve within 7 days or if you develop a high fever or persistent headache, check with your doctor.


• Respa-AR Sustained-Release Tablets may cause dry mouth. To relieve dry mouth, suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute.


• Respa-AR Sustained-Release Tablets may cause your eyes to become sensitive to sunlight. Wearing sunglasses may help.


• Respa-AR Sustained-Release Tablets may reduce sweating. Do not become overheated in hot weather or during exercise or other activities; heatstroke may occur.


• Do not take diet or appetite control medicines while you are taking Respa-AR Sustained-Release Tablets without checking with your doctor.


• Respa-AR Sustained-Release Tablets contains pseudoephedrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains pseudoephedrine. If it does or if you are uncertain, contact your doctor or pharmacist.


• If you have trouble sleeping, ask your doctor or pharmacist about the best time of the day to take Respa-AR Sustained-Release Tablets.


• Respa-AR Sustained-Release Tablets may interfere with certain lab test results. Be sure your doctors and lab personnel know that you are taking Respa-AR Sustained-Release Tablets.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Respa-AR Sustained-Release Tablets.


• Diabetes patients - Respa-AR Sustained-Release Tablets may affect your blood sugar. Check blood sugar levels closely and ask your doctor before adjusting the dose of your diabetes medicine.


• Caution is advised when using Respa-AR Sustained-Release Tablets the ELDERLY because they may be more sensitive to its effects.


• Caution is advised when using Respa-AR Sustained-Release Tablets in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: It is unknown if Respa-AR Sustained-Release Tablets can cause harm to the fetus. If you become pregnant while taking Respa-AR Sustained-Release Tablets, discuss with your doctor the benefits and risks of using Respa-AR Sustained-Release Tablets during pregnancy. Respa-AR Sustained-Release Tablets are excreted in breast milk. Do not breast-feed while taking Respa-AR Sustained-Release Tablets.

Possible side effects of Respa-AR Sustained-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; mental or mood changes; seizures; severe dizziness, lightheadedness, or headache; tremor; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Respa-AR side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include deep sleep or loss of consciousness; hot or cool skin; irregular heartbeat; irritability, anxiety, or panic; large pupils; numbness or tingling in the arms or legs; seizures; slowed or shallow breathing.

Proper storage of Respa-AR Sustained-Release Tablets:

Store Respa-AR Sustained-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Respa-AR Sustained-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Respa-AR Sustained-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Respa-AR Sustained-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Respa-AR Sustained-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Respa-AR resources

• Respa-AR Side Effects (in more detail)
• Respa-AR Use in Pregnancy & Breastfeeding
• Respa-AR Drug Interactions
• Respa-AR Support Group
• 6 Reviews for Respa-AR - Add your own review/rating

Compare Respa-AR with other medications

• Sinus Symptoms